Valtruis invests in, builds, and partners with companies that challenge the healthcare industry’s status quo and revolutionize the way care is accessed, delivered, experienced, and paid for. Founded on a commitment to accelerate meaningful change, Valtruis brings the functional expertise, access to capital and an expansive network that advance our partners’ evolution from early-stage development to industry-leading enterprises. Together, Valtruis and its partner companies will break through the systemic barriers in the healthcare industry to reduce costs, expand access, increase quality and radically improve the patient experience.
9
Total Investments
7
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Financial Services, Health Care
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Valtruis
Recent Investments (9)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Early VC | •••••• | Mar 2026 | |
| Series A | •••••• | Jun 2025 | |
| Series B | •••••• | May 2024 | |
| Series D | •••••• | May 2024 | |
| Series B | •••••• | Mar 2024 | |
|
|
Series B | •••••• | Mar 2023 |
|
|
Series A | •••••• | Oct 2022 |
|
|
Venture Round | •••••• | Nov 2021 |
|
|
Series D | •••••• | Sep 2021 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.